Knight Therapeutics | GUD - Trade Creditors



Knight Therapeutics reported 86.03M in Trade Creditors for its fiscal quarter ending in March of 2024.


Trade Creditors Change Date
Acasti Pharma USD 1.34M 1.34M Jun/2025
Alaunos Therapeutics USD 516K 58K Dec/2024
Aurora Cannabis CAD 81.29M 51.77M Jun/2025
Avita Medical 6.29M 2.13M Dec/2024
Canopy Growth CAD 24.08M 4.84M Jun/2025
Cronos Group USD 12.14M 2.64M Jun/2025
Dianthus Therapeutics USD 5.4M 825K Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
IQVIA Holdings 3.4B 160M Jun/2025
Moderna USD 175M 51M Jun/2025
Organigram Holdings 89.8M 26.46M Jun/2025
Organon & Co USD 1.07B 61M Jun/2025
Revvity USD 178.15M 65K Jun/2025
Tectonic Therapeutic USD 2.8M 1.82M Jun/2025
Tilray USD 99.08M 2.79M Nov/2024
Viatris USD 1.32B 198.2M Jun/2025
Xeris Pharmaceuticals USD 9.46M 7.17M Jun/2025